SCWorx Corp. reports developments around its software-as-a-service data management platform for healthcare providers. Company news commonly covers customer agreements, partner-led sales channels, Workday ERP data readiness projects, data cleanse and normalization work, master data governance, interoperability, and healthcare supply chain analytics.
Updates also address renewals with healthcare partners, expansion of solution modules such as Virtual Item Master, contract management, automated rebate management, Virtual General Ledger, and data analytics, as well as corporate matters including technology leadership and Nasdaq listing-compliance actions.
SCWorx (WORX) has entered into a new agreement to provide healthcare supply chain data management services to a healthcare system. The new customer is an independent, community-owned system serving New Mexico, Arizona, Colorado and Utah.
The services will support the health system’s efforts to improve the accuracy, completeness and usability of its healthcare product data. The agreement expands SCWorx’s healthcare provider customer base and supports its stated strategy of growing recurring revenue through new customer relationships.
SCWorx (Nasdaq: WORX) resumed trading on The Nasdaq Capital Market after regaining compliance with Nasdaq's continued listing requirements. Continued listing is subject to conditions, including a one-year Panel Monitor.
Unaudited first-half 2026 revenue was approximately $1.45 million, versus approximately $1.40 million a year earlier. Gross profit increased approximately 122% to $705,000. Net loss narrowed to approximately $295,000 from $2.4 million, partly because convertible-note expenses no longer applied. Operating cash used fell to approximately $258,000 from $1.1 million. Cash was approximately $1.3 million at June 30; a September stock-and-warrant placement raised $938,000 gross.
New healthcare business included a two-year agreement with a Massachusetts integrated delivery network. SCWorx plans to expand customers and recurring revenue and improve margins through automation.
SCWorx (Nasdaq: WORX) announced that its common stock will resume trading on Nasdaq at the open on October 7, 2026. Nasdaq notified the healthcare data management company that its common stock will be reinstated for trading on The Nasdaq Stock Market.
SCWorx (WORX) won approval on October 2, 2026, to continue its Nasdaq Capital Market listing after the Hearings Panel reconsidered its delisting decision. The Panel found compliance with continued listing requirements, including minimum bid price and publicly held shares. Nasdaq trading, suspended since April 14, 2026, will resume on a date Nasdaq sets; shares remain quoted on OTCQB until then.
A September 16 private placement and warrant exercises increased publicly held shares to 549,092 as of September 17, above the 500,000-share minimum. Closing bids have remained at least $1.00 since August 4, 2026. Placement investors agreed not to terminate their purchases based on the September 17 delisting decision. Continued listing includes a one-year monitoring period ending October 2, 2027 and monthly share reports through October 5, 2027. Any listing-standard failure during monitoring would trigger a delisting determination without a compliance plan or cure period.
SCWorx (WORX) entered a Securities Purchase Agreement with institutional and accredited investors for an equity financing with gross proceeds of approximately $938,000. The company will sell 350,000 Units, each comprising one share of common stock and one warrant to purchase one share, at $2.68 per Unit, with warrants exercisable immediately at $2.56 per share for five years. Existing investors exercised warrants for 50,000 shares, and about 50,000 shares will be issued to the placement agent, which is expected to increase Publicly Held Shares above 500,000 to address Nasdaq Rule 5550(a)(4). Proceeds will be held in a segregated account until November 30, 2026, and investors may require repayment if Nasdaq trading does not resume or a delisting determination occurs under specified dates.
SCWorx (NASDAQ: WORX) announced a new two-year agreement with one of Massachusetts’ largest integrated delivery networks, a leading not-for-profit healthcare organization spanning hospitals, physician practices, outpatient facilities, and community-based services.
SCWorx will deliver its proprietary healthcare data normalization, item master management, and supply chain data enrichment solutions to enhance data quality, governance, and operational efficiency. According to SCWorx, the engagement is expected to support procurement optimization, stronger data governance, and more effective analytics, and reinforces demand from complex health systems for accurate, normalized, and actionable supply chain data.
SCWorx (Nasdaq: WORX) announced that it received a partial compliance letter from the Nasdaq Hearings Panel, confirming completion of the first benchmark in its plan to regain full compliance for continued listing on the Nasdaq Capital Market. Under the Panel’s decision, SCWorx must still achieve a minimum closing bid price of $1.00 per share for at least 20 consecutive trading days, as required by Nasdaq Listing Rule 5815(c)(4). The company must promptly inform Nasdaq of any material changes to its compliance plan or circumstances affecting its ability to meet the exception’s conditions, and the Panel has reserved the right to reconsider the exception terms. SCWorx’s CEO stated that maintaining the Nasdaq listing is a strategic priority and that the company intends to take all actions necessary to satisfy the Panel’s conditions and update investors on its progress.
SCWorx (WORX) announced deployment of its AI-assisted Data Management Model for healthcare supply chain data. The platform integrates commercially available large language models, including Anthropic models, with SCWorx’s proprietary healthcare product databases, attribute catalog, UNSPSC-based classification and human QA.
The model targets faster data cleansing, enrichment, classification and governance, aiming to improve attribute recognition, consistency, workflow automation, and internal productivity while supporting hospitals, distributors and ERP platforms with more accurate and actionable supply chain information.
SCWorx (NASDAQ: WORX) announced a new agreement with a prominent not-for-profit teaching hospital in Florida to provide healthcare data management and normalization services supporting the hospital’s Workday ERP implementation.
SCWorx will cleanse, standardize, enrich, and optimize item master and supply chain data, expanding its healthcare customer portfolio.
SCWorx (Nasdaq: WORX) received a Nasdaq Hearings Panel decision allowing its listing to continue, subject to strict compliance conditions after a trading suspension on April 14, 2026 for failing the $1.00 minimum bid price rule.
Conditions include shareholder approval of a reverse stock split by July 22, 2026, effecting the split by August 3, 2026, and regaining a closing bid ≥ $1.00 for at least 20 consecutive trading days by August 28, 2026. Failure would lead to Nasdaq delisting, with shares remaining quoted on OTCQB, subject to applicable rules.